Recognizes the 50th anniversary of the establishment of the National Microbiological Institute, now known as the National Institute of Allergy and Infectious Diseases (NIAID).
Reaffirms support of the NIAID and its commitment to advance knowledge and improve health.
[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 335 Introduced in House (IH)]
105th CONGRESS
2d Session
H. CON. RES. 335
Recognizing the 50th anniversary of the National Institute of Allergy
and Infectious Diseases, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
October 7, 1998
Mrs. Northup (for herself and Mr. Young of Florida) submitted the
following concurrent resolution; which was referred to the Committee on
Commerce
_______________________________________________________________________
CONCURRENT RESOLUTION
Recognizing the 50th anniversary of the National Institute of Allergy
and Infectious Diseases, and for other purposes.
Whereas November 1998 marks the 50th anniversary of the establishment of the
National Microbiological Institute, predecessor of the National
Institute of Allergy and Infectious Diseases, under authority of section
202 of the Public Health Service Act;
Whereas the Institute was formed through the combination of the Rocky Mountain
Laboratory, the Biologics Control Laboratory, and the Divisions of
Infectious Diseases and Tropical Diseases of the National Institutes of
Health;
Whereas in 1955 Congress renamed the National Microbiological Institute as the
National Institute of Allergy and Infectious Diseases (NIAID) in
recognition of the need for a coordinated scientific research program on
infectious, allergic, and immunologic diseases;
Whereas the research conducted by the National Institute of Allergy and
Infectious Diseases encompasses infectious diseases such as acquired
immunodeficiency syndrome (AIDS), tuberculosis, sexually transmitted
diseases, malaria, and influenza, immunologic diseases (including
asthma, allergies, and primary immune deficiency diseases),
transplantation immunology, and the development of new diagnostic
therapies and vaccines for infectious diseases;
Whereas research supported by the NIAID continues to yield promising advances,
including the development of vaccines against human immunodeficiency
virus (HIV) and the identification of effective treatment regimens for
childhood asthma;
Whereas the continued threat of emerging and re-emerging infectious diseases,
such as tuberculosis, poses a risk to health worldwide;
Whereas research supported by the NIAID provides the necessary tools to develop
diagnostic tests, new and improved treatments, vaccines, and other means
to combat microbial threats of today and those of the future;
Whereas research supported by the NIAID is making significant progress in
understanding the immune system and its disorders, including the
mechanisms of immune tolerance, which refers to the ability of the
immune system to distinguish between cells and tissues that are ``self''
and those that are foreign or ``non-self'', such as a pathogen, tumor,
or transplanted organ;
Whereas this progress is vital to the field of organ transplantation and may
prove useful in treating autoimmune diseases such as rheumatoid
arthritis and multiple sclerosis; and
Whereas the Congress intends that the National Institute of Allergy and
Infectious Diseases continue its innovative leadership in delineating
pathogenesis, improving diagnosis and treatment, and developing vaccines
to prevent infectious and immunologic diseases, thereby contributing to
the overall health of the American public and the people of the world:
Now, therefore, be it
Resolved by the House of Representatives (the Senate concurring),
That the Congress--
(1) recognizes the historic significance of the 50th
anniversary of the establishment of the National
Microbiological Institute, now known as the National Institute
of Allergy and Infectious Diseases;
(2) recognizes the research scientists, administrative
staff, professional societies, and patient groups of the NIAID
for their active participation in support of the research
programs and goals of the NIAID; and
(3) reaffirms its support of the National Institute of
Allergy and Infectious Diseases and of the commitment of the
NIAID to advance knowledge and improve health.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Commerce.
Sponsor introductory remarks on measure. (CR E1948-1949)
Referred to the Subcommittee on Health and Environment.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line